These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 17274663)
1. Vaccine delivery methods using viral vectors. Bråve A; Ljungberg K; Wahren B; Liu MA Mol Pharm; 2007; 4(1):18-32. PubMed ID: 17274663 [TBL] [Abstract][Full Text] [Related]
2. Plasmid DNA and viral vector-based vaccines for the treatment of cancer. Anderson RJ; Schneider J Vaccine; 2007 Sep; 25 Suppl 2():B24-34. PubMed ID: 17698262 [TBL] [Abstract][Full Text] [Related]
3. Strategies for DNA vaccine delivery. Alpar HO; Papanicolaou I; Bramwell VW Expert Opin Drug Deliv; 2005 Sep; 2(5):829-42. PubMed ID: 16296781 [TBL] [Abstract][Full Text] [Related]
7. Bacterial vectors and delivery systems in cancer therapy. Gardlik R; Fruehauf JH IDrugs; 2010 Oct; 13(10):701-6. PubMed ID: 20878592 [TBL] [Abstract][Full Text] [Related]
8. Use of viral vectors for the development of vaccines. Liniger M; Zuniga A; Naim HY Expert Rev Vaccines; 2007 Apr; 6(2):255-66. PubMed ID: 17408374 [TBL] [Abstract][Full Text] [Related]
10. Applications of Hemagglutinating Virus of Japan in therapeutic delivery systems. Kaneda Y Expert Opin Drug Deliv; 2008 Feb; 5(2):221-33. PubMed ID: 18248320 [TBL] [Abstract][Full Text] [Related]
11. Multiple alternating immunizations with DNA vaccine and replication incompetent adenovirus expressing gB of pseudorabies virus protect animals against lethal virus challenge. Kim SJ; Kim HK; Han YW; Aleyas AG; George JA; Yoon HA; Yoo DJ; Kim K; Eo SK J Microbiol Biotechnol; 2008 Jul; 18(7):1326-34. PubMed ID: 18667863 [TBL] [Abstract][Full Text] [Related]
12. Immunologic basis of vaccine vectors. Liu MA Immunity; 2010 Oct; 33(4):504-15. PubMed ID: 21029961 [TBL] [Abstract][Full Text] [Related]
13. Optimization and delivery of plasmid DNA for vaccination. Jechlinger W Expert Rev Vaccines; 2006 Dec; 5(6):803-25. PubMed ID: 17184219 [TBL] [Abstract][Full Text] [Related]
14. Bacteriophages as tools for vaccine and drug development. Manoutcharian K Expert Rev Vaccines; 2005 Feb; 4(1):5-7. PubMed ID: 15757465 [No Abstract] [Full Text] [Related]
15. Toward development of artificial viruses for gene therapy: a comparative evaluation of viral and non-viral transfection. Douglas KL Biotechnol Prog; 2008; 24(4):871-83. PubMed ID: 18335953 [TBL] [Abstract][Full Text] [Related]
16. Oral delivery of DNA vaccine encoding VP28 against white spot syndrome virus in crayfish by attenuated Salmonella typhimurium. Ning JF; Zhu W; Xu JP; Zheng CY; Meng XL Vaccine; 2009 Feb; 27(7):1127-35. PubMed ID: 19071178 [TBL] [Abstract][Full Text] [Related]
17. The efficiency of a novel delivery system (PEI600-Tat) in development of potent DNA vaccine using HPV16 E7 as a model antigen. Bolhassani A; Ghasemi N; Servis C; Taghikhani M; Rafati S Drug Deliv; 2009 May; 16(4):196-204. PubMed ID: 19514980 [TBL] [Abstract][Full Text] [Related]
18. Enhanced in vivo transgene expression and immunogenicity from plasmid vectors following electrostimulation in rodents and primates. Simon AJ; Casimiro DR; Finnefrock AC; Davies ME; Tang A; Chen M; Chastain M; Kath GS; Chen L; Shiver JW Vaccine; 2008 Sep; 26(40):5202-9. PubMed ID: 18472195 [TBL] [Abstract][Full Text] [Related]